Meanwhile, our findings from subcutaneous and intracardiac xenograft tumor models indicated that HOXA5 upregulation was sufficient to reduce tumor sizes and distant metastases, thus supporting the tumor-suppressive role of HOXA5 in PCa progression. This evidence concerns the gene HOXA5 and neoplasm.